These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2376799)

  • 1. [Effect of platelet-activating factor on nasal vascular permeability and eosinophil accumulation in guinea pigs].
    Shirasaki H; Asakura K
    Nihon Jibiinkoka Gakkai Kaiho; 1990 Apr; 93(4):615-21. PubMed ID: 2376799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor (PAF)-induced rhinitis and involvement of PAF in allergic rhinitis in guinea pigs.
    Misawa M; Iwamura S
    Jpn J Pharmacol; 1990 Oct; 54(2):217-26. PubMed ID: 2077186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of thromboxane A2 and histamine in experimental allergic rhinitis of guinea pigs.
    Yamasaki M; Matsumoto T; Fukuda S; Nakayama T; Nagaya H; Ashida Y
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1471-9. PubMed ID: 9067337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
    Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
    Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of azelastine on nasal allergic responses in sensitized guinea pigs.
    Shirasaki H; Asakura K; Sohma S; Kataura A
    Eur Arch Otorhinolaryngol; 1992; 249(5):279-82. PubMed ID: 1381925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of anti-PAF agents on nasal response after allergen challenge in guinea pigs].
    Narita S; Asakura K; Shirasaki H; Kojima T; Saitoh H; Kataura A
    Nihon Jibiinkoka Gakkai Kaiho; 1992 Aug; 95(8):1190-7. PubMed ID: 1357119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of a novel thienodiazepine derivative as a platelet-activating factor antagonist in guinea pig lungs. Effects on platelet-activating factor and allergen induced eosinophil accumulation.
    Tsunoda H; Sakuma Y; Shirato M; Obaishi H; Harada K; Yamada K; Shimomura N; Machida Y; Yamatsu I; Katayama K
    Arzneimittelforschung; 1991 Mar; 41(3):224-7. PubMed ID: 1867658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of platelet-activating factor in nasal lavage fluid from patients with pollinosis and experimental animals with nasal allergy].
    Shirasaki H; Asakura K
    Nihon Jibiinkoka Gakkai Kaiho; 1990 Mar; 93(3):420-7. PubMed ID: 2352050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of platelet activating factor (PAF) in histamine-induced model of nasal allergy in rats.
    Akagi M; Kanoh R; Fukuishi N; Tachibana M; Akagi R
    Arerugi; 1995 Mar; 44(3 Pt 1):182-8. PubMed ID: 7646374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of anti-PAF and other agents on the nasal symptoms in sensitized guinea pigs.
    Narita S; Asakura K
    Auris Nasus Larynx; 1993; 20(3):175-83. PubMed ID: 7905260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of interleukin-5 in enhanced migration of eosinophils from airways of immunized guinea-pigs.
    Coëffier E; Joseph D; Vargaftig BB
    Br J Pharmacol; 1994 Nov; 113(3):749-56. PubMed ID: 7858864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of amlexanox on experimental allergic rhinitis in actively sensitized guinea pigs].
    Ukai K; Atsushi ; Yuda ; Nonoyama T; Sakakura Y; Ahida Y
    Arerugi; 1990 Jan; 39(1):54-8. PubMed ID: 2350243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABT-491, a highly potent and selective PAF antagonist, inhibits nasal vascular permeability associated with experimental allergic rhinitis in brown Norway rats.
    Albert DH; Tapang P; Morgan DW; Curtin ML; Sheppard GS; Davidsen SK; Summers JB; Carter GW
    Inflamm Res; 1997 Aug; 46 Suppl 2():S133-4. PubMed ID: 9297547
    [No Abstract]   [Full Text] [Related]  

  • 14. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists.
    Lellouch-Tubiana A; Lefort J; Simon MT; Pfister A; Vargaftig BB
    Am Rev Respir Dis; 1988 Apr; 137(4):948-54. PubMed ID: 3281530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of platelet-activating factor (PAF) and the efficacy of ABT-491, a highly potent and selective PAF antagonist, in experimental allergic rhinitis.
    Albert DH; Malo PE; Tapang P; Shaughnessy TK; Morgan DW; Wegner CD; Curtin ML; Sheppard GS; Xu L; Davidsen SK; Summers JB; Carter GW
    J Pharmacol Exp Ther; 1998 Jan; 284(1):83-8. PubMed ID: 9435164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and localization of platelet-activating factor receptor in human nasal mucosa.
    Shirasaki H; Seki N; Kikuchi M; Kanaizumi E; Watanabe K; Konno N; Himi T
    Ann Allergy Asthma Immunol; 2005 Aug; 95(2):190-6. PubMed ID: 16136770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal eosinophilia induced by PAF-acether is accompanied by the release of eosinophil cationic protein.
    Tedeschi A; Milazzo N; Miadonna A
    Eur Respir J; 1994 Aug; 7(8):1445-51. PubMed ID: 7525344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathophysiological role of kinin and chemical mediators on experimental allergic rhinitis.
    Shirasaki H; Kojima T; Asakura K; Kataura A; Shimamoto K; Iimura O
    Adv Exp Med Biol; 1989; 247A():375-8. PubMed ID: 2603805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a cysteinyl leukotriene antagonist, ONO-1078 (pranlukast), on total airway resistance after antigen challenge in sensitized guinea pigs.
    Narita S; Asakura K; Shirasaki H; Kataura A
    Inflamm Res; 1997 Apr; 46(4):143-6. PubMed ID: 9137993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of thromboxane A2 receptor antagonist (Bay u 3405) on nasal symptoms after antigen challenge in sensitized guinea pigs.
    Narita S; Asakura K; Kataura A
    Int Arch Allergy Immunol; 1996 Feb; 109(2):161-6. PubMed ID: 8563491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.